Prevention and treatment of hepatic veno-occlusive disease |
| |
Authors: | Carreras Enric |
| |
Affiliation: | Consultor Senior, Hospital Clínic, Barcelona, España. Director de REDMO-Fundación Josep Carreras contra la Leucemia, Barcelona, España |
| |
Abstract: | Hematopoietic stem cell transplantation is currently the main cause of hepatic veno-occlusive disease, which is the early complication of this procedure with the highest short-term morbidity and mortality.Given that mortality from severe hepatic veno-occlusive disease can be nearly 100%, the search for measures to prevent of treat this complication is essential.Several risk factors for this complication have been identified and the triggering event that leads to sinusoidal obstruction has been shown to be sinusoidal endothelial cell injury.The present review analyzes measures to avoid or modify the casual risk factors for this complication, as well as the pharmacological agents that can prevent or modify the initial endothelial dysfunction or the resulting sinusoidal occlusion. |
| |
Keywords: | Enfermedad venooclusiva hepá tica Sí ndrome de obstrucció n sinusoidal Trasplante de progenitores hematopoyé ticos Defibró tido Profilaxis y tratamiento complicaciones precoces trasplante hematopoyé tico |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|